GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Laboratorio Reig Jofre SA (XMAD:RJF) » Definitions » Stock Based Compensation

Laboratorio Reig Jofre (XMAD:RJF) Stock Based Compensation : €0.0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Laboratorio Reig Jofre Stock Based Compensation?

Laboratorio Reig Jofre's Stock Based Compensation for the three months ended in Dec. 2023 was €0.0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2023 was €0.0 Mil.

Laboratorio Reig Jofre Stock Based Compensation Historical Data

The historical data trend for Laboratorio Reig Jofre's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laboratorio Reig Jofre Stock Based Compensation Chart

Laboratorio Reig Jofre Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Laboratorio Reig Jofre Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Laboratorio Reig Jofre Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

Laboratorio Reig Jofre Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Laboratorio Reig Jofre's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.

Laboratorio Reig Jofre (XMAD:RJF) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Laboratorio Reig Jofre SA (XMAD:RJF) » Definitions » Stock Based Compensation
Comparable Companies
XMAD:OPDE XMAD:ECR XMAD:MDF XMAD:DOM XMAD:SLR XMAD:FAE XMAD:LRE XMAD:ISUR XMAD:TRE XMAD:TUB ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ VTRS SZSE:000538 NBIX
Traded in Other Exchanges
FEQ1:Germany
Address
Avenida de les Flors, Sant Joan Despi, Barcelona, ESP, 08970
Website
http://www.reigjofre.com
Laboratorio Reig Jofre SA is a healthcare and pharmaceutical developing company. The company focuses on the development of technological-specialization products (antibiotics and injectable products); therapeutic-specialization products in the areas of dermatology, gynecology and respiratory; and consumer healthcare products. It has a broad portfolio of products that the company divides into three categories: products from specialized technology such as antibiotics, injectable, and freeze-dried products.